Opko Health Stock Analysis
OPK Stock | USD 1.37 0.02 1.48% |
Opko Health is undervalued with Real Value of 2.02 and Target Price of 3.99. The main objective of Opko Health stock analysis is to determine its intrinsic value, which is an estimate of what Opko Health is worth, separate from its market price. There are two main types of Opko Health's stock analysis: fundamental analysis and technical analysis.
The Opko Health stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. Opko Stock Analysis Notes
About 47.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.82. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Opko Health recorded a loss per share of 0.06. The entity had not issued any dividends in recent years. OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company was founded in 1991 and is headquartered in Miami, Florida. Opko Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5767 people. To find out more about Opko Health contact Phillip Frost at 305 575 4100 or learn more at https://www.opko.com.Opko Health Investment Alerts
Opko Health generated a negative expected return over the last 90 days | |
Opko Health may become a speculative penny stock | |
The company reported the last year's revenue of 713.14 M. Reported Net Loss for the year was (53.22 M) with profit before taxes, overhead, and interest of 104.94 M. | |
Opko Health has about 210.46 M in cash with (183.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. | |
Roughly 47.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from thelincolnianonline.com: OPKO Health Upgraded at LADENBURG THALMSH SH |
Opko Health Upcoming and Recent Events
22nd of February 2024 Upcoming Quarterly Report | View | |
1st of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
22nd of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Opko Largest EPS Surprises
Earnings surprises can significantly impact Opko Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2016-02-29 | 2015-12-31 | 0.0017 | 0.0029 | 0.0012 | 70 | ||
2023-11-06 | 2023-09-30 | -0.1 | -0.11 | -0.01 | 10 | ||
2021-02-18 | 2020-12-31 | 0.04 | 0.05 | 0.01 | 25 |
Opko Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Bank Of America Corp | 2025-03-31 | 4.2 M | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 4.1 M | Goldman Sachs Group Inc | 2025-03-31 | 4 M | Lazard Asset Management Llc | 2025-03-31 | 3.6 M | Northern Trust Corp | 2025-03-31 | 3.5 M | Charles Schwab Investment Management Inc | 2025-03-31 | 2.7 M | Jpmorgan Chase & Co | 2025-03-31 | 2.5 M | Ubs Group Ag | 2025-03-31 | 2.4 M | Dimensional Fund Advisors, Inc. | 2025-03-31 | 2.2 M | Rubric Capital Management Lp | 2025-03-31 | 48.7 M | Vanguard Group Inc | 2025-03-31 | 29.5 M |
Opko Market Capitalization
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.07 B.Opko Profitablity
The company has Net Profit Margin of (0.06) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.45) %, which entails that for every $100 of revenue, it lost $0.45.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.06) | (0.06) | |
Return On Capital Employed | (0.08) | (0.08) | |
Return On Assets | (0.02) | (0.03) | |
Return On Equity | (0.04) | (0.04) |
Management Efficiency
Opko Health has Return on Asset of (0.082) % which means that on every $100 spent on assets, it lost $0.082. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0304) %, meaning that it generated no profit with money invested by stockholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.07. The value of Return On Capital Employed is expected to slide to -0.08. At this time, Opko Health's Liabilities And Stockholders Equity is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 673.8 M this year, although the value of Total Current Liabilities will most likely fall to about 107.5 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 1.97 | 1.19 | |
Tangible Book Value Per Share | 0.04 | 0.03 | |
Enterprise Value Over EBITDA | 8.08 | 8.48 | |
Price Book Value Ratio | 0.75 | 0.71 | |
Enterprise Value Multiple | 8.08 | 8.48 | |
Price Fair Value | 0.75 | 0.71 | |
Enterprise Value | 1.1 B | 1.4 B |
Effective leadership at Opko Health drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Technical Drivers
As of the 21st of July, Opko Health holds the Variance of 4.55, risk adjusted performance of (0.02), and Coefficient Of Variation of (3,937). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Opko Health, as well as the relationship between them.Opko Health Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Opko Health for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Opko Health short-term fluctuations and highlight longer-term trends or cycles.
Opko Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opko Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opko Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Opko Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Opko Health Outstanding Bonds
Opko Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Opko Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Opko bonds can be classified according to their maturity, which is the date when Opko Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
US683715AD87 Corp BondUS683715AD87 | View | |
OTEXCN 69 01 DEC 27 Corp BondUS683715AF36 | View | |
Open Text Corp BondUS683715AC05 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
US683720AC08 Corp BondUS683720AC08 | View | |
Open Text Corp BondUS683720AA42 | View |
Opko Health Predictive Daily Indicators
Opko Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Opko Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Opko Health Forecast Models
Opko Health's time-series forecasting models are one of many Opko Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Opko Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Opko Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Opko Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Opko shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Opko Health. By using and applying Opko Stock analysis, traders can create a robust methodology for identifying Opko entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.01) | (0.02) | |
Operating Profit Margin | (0.21) | (0.22) | |
Net Loss | (0.07) | (0.08) | |
Gross Profit Margin | 0.44 | 0.39 |
Current Opko Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Opko analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Opko analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
3.99 | Strong Buy | 7 | Odds |
Most Opko analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Opko stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Opko Health, talking to its executives and customers, or listening to Opko conference calls.
Opko Stock Analysis Indicators
Opko Health stock analysis indicators help investors evaluate how Opko Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Opko Health shares will generate the highest return on investment. By understating and applying Opko Health stock analysis, traders can identify Opko Health position entry and exit signals to maximize returns.
Begin Period Cash Flow | 95.9 M | |
Long Term Debt | 422.2 M | |
Common Stock Shares Outstanding | 694 M | |
Total Stockholder Equity | 1.4 B | |
Total Cashflows From Investing Activities | 352.2 M | |
Tax Provision | 42.8 M | |
Quarterly Earnings Growth Y O Y | 0.191 | |
Property Plant And Equipment Net | 124.1 M | |
Cash And Short Term Investments | 431.9 M | |
Cash | 431.9 M | |
Accounts Payable | 47.1 M | |
Net Debt | 72.5 M | |
50 Day M A | 1.3248 | |
Total Current Liabilities | 193.1 M | |
Other Operating Expenses | 865.2 M | |
Non Current Assets Total | 1.5 B | |
Forward Price Earnings | 64.5161 | |
Non Currrent Assets Other | 18.5 M | |
Stock Based Compensation | 11 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.14) | Return On Assets |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.